▶ VideoClinical Research
Long COVID & Psychedelics: Can Psilocybin and MDMA Support Recovery?
An examination of emerging evidence for psychedelic-assisted therapy in Long COVID — including the published case report of MDMA and psilocybin reversing persistent Long-COVID symptoms, proposed mechanisms involving neuroinflammation and serotonin signaling, and the research agenda this opens.
psilocybinLong COVIDMDMApsychedelicspost-COVIDneuroinflammationpsilocybe cubensis
Source Research Papers
Citations in APA 7 format. All studies were sourced from peer-reviewed journals via Google Scholar.
Chopra, H., Furnish, T., Verduzco-Gutierrez, M., Jevotovsky, D. S., & Castellanos, J. (2024). Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report. Clinical Case Reports, 12, e8791. https://doi.org/10.1002/ccr3.8791
Shop Related Spores
Laboratory-grade Psilocybe cubensis spore syringes for microscopy research.